These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31012282)

  • 1. Matrix metalloproteinase-9 gene polymorphisms are associated with ischemic stroke severity and early neurologic deterioration in patients with atrial fibrillation.
    Yi X; Zhou Q; Sui G; Fan D; Zhang Y; Shao M; Han Z; Luo H; Lin J; Zhou J
    Brain Behav; 2019 Jun; 9(6):e01291. PubMed ID: 31012282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial Stroke Severity in Patients With Atrial Fibrillation According to Antithrombotic Therapy Before Ischemic Stroke.
    Jung YH; Kim YD; Kim J; Han SW; Oh MS; Lee JS; Lee KY
    Stroke; 2020 Sep; 51(9):2733-2741. PubMed ID: 32811392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variants in matrix metalloproteinase-9 gene are associated with hemorrhagic transformation in acute ischemic stroke patients with atherothrombosis, small artery disease, and cardioembolic stroke.
    Yi X; Sui G; Zhou Q; Wang C; Lin J; Chai Z; Zhou J
    Brain Behav; 2019 Jun; 9(6):e01294. PubMed ID: 31074588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preceding Antithrombotic Treatment is Associated With Acute Ischemic Stroke Severity and Functional Outcome at 90 Days Among Patients With Atrial Fibrillation.
    Yi X; Lin J; Han Z; Luo H; Shao M; Fan D; Zhou Q
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):2003-2010. PubMed ID: 31047821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial Fibrillation.
    Xian Y; O'Brien EC; Liang L; Xu H; Schwamm LH; Fonarow GC; Bhatt DL; Smith EE; Olson DM; Maisch L; Hannah D; Lindholm B; Lytle BL; Pencina MJ; Hernandez AF; Peterson ED
    JAMA; 2017 Mar; 317(10):1057-1067. PubMed ID: 28291892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prestroke CHA
    Acciarresi M; Paciaroni M; Agnelli G; Falocci N; Caso V; Becattini C; Marcheselli S; Rueckert C; Pezzini A; Morotti A; Costa P; Padovani A; Csiba L; Szabó L; Sohn SI; Tassinari T; Abdul-Rahim AH; Michel P; Cordier M; Vanacker P; Remillard S; Alberti A; Venti M; D'Amore C; Scoditti U; Denti L; Orlandi G; Chiti A; Gialdini G; Bovi P; Carletti M; Rigatelli A; Putaala J; Tatlisumak T; Masotti L; Lorenzini G; Tassi R; Guideri F; Martini G; Tsivgoulis G; Vadikolias K; Liantinioti C; Corea F; Del Sette M; Ageno W; De Lodovici ML; Bono G; Baldi A; D'Anna S; Sacco S; Carolei A; Tiseo C; Imberti D; Zabzuni D; Doronin B; Volodina V; Consoli D; Galati F; Pieroni A; Toni D; Monaco S; Baronello MM; Barlinn K; Pallesen LP; Kepplinger J; Bodechtel U; Gerber J; Deleu D; Melikyan G; Ibrahim F; Akhtar N; Mosconi MG; Lees KR
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1363-1368. PubMed ID: 28236595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between stroke severity and prior direct oral anticoagulant therapy in patients with acute ischaemic stroke and non-valvular atrial fibrillation.
    Sakamoto Y; Okubo S; Nito C; Suda S; Matsumoto N; Abe A; Aoki J; Shimoyama T; Takayama Y; Suzuki K; Mishina M; Kimura K
    Eur J Neurol; 2017 Nov; 24(11):1399-1406. PubMed ID: 28799181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prestroke Statins Improve Prognosis of Atrial Fibrillation-Associated Stroke through Increasing Suppressor of Cytokine Signaling-3 Levels.
    Lu T; Yang X; Cai Y; Xie C; Zhang B
    Eur Neurol; 2021; 84(2):96-102. PubMed ID: 33684912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-vitamin K oral anticoagulants as first-line regimen for acute ischemic stroke with non-valvular atrial fibrillation.
    Park CW; Nam HS; Heo JH; Park HJ; Choi JK; Lee HS; Na HK; Kim YD
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105025. PubMed ID: 32807440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of atrial fibrillation and inadequate antithrombotic management on mortality in acute neurovascular syndrome.
    Saarinen JT; Rusanen H; Sillanpää N; Huhtala H; Numminen H; Elovaara I
    J Stroke Cerebrovasc Dis; 2014 Oct; 23(9):2256-64. PubMed ID: 25156784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between high-sensitivity C-reactive protein and early neurological deterioration in stroke patients with and without atrial fibrillation.
    Duan Z; Guo W; Tang T; Tao L; Gong K; Zhang X
    Heart Lung; 2020; 49(2):193-197. PubMed ID: 31699451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated.
    Gladstone DJ; Bui E; Fang J; Laupacis A; Lindsay MP; Tu JV; Silver FL; Kapral MK
    Stroke; 2009 Jan; 40(1):235-40. PubMed ID: 18757287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the Matrix Metalloproteinase-9 rs3918242 Polymorphism and Ischemic Stroke Susceptibility: A Meta-Analysis.
    He T; Wang J; Wang XL; Deng WS; Sun P
    J Stroke Cerebrovasc Dis; 2017 May; 26(5):1136-1143. PubMed ID: 28258806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prestroke and Poststroke Antithrombotic Therapy in Patients With Atrial Fibrillation: Results From a Nationwide Cohort.
    Gundlund A; Xian Y; Peterson ED; Butt JH; Gadsbøll K; Bjerring Olesen J; Køber L; Torp-Pedersen C; Gislason GH; Loldrup Fosbøl E
    JAMA Netw Open; 2018 May; 1(1):e180171. PubMed ID: 30646049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006.
    Béjot Y; Ben Salem D; Osseby GV; Couvreur G; Durier J; Marie C; Cottin Y; Moreau T; Giroud M
    Neurology; 2009 Jan; 72(4):346-53. PubMed ID: 19171832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation is associated with severe acute ischemic stroke.
    Dulli DA; Stanko H; Levine RL
    Neuroepidemiology; 2003; 22(2):118-23. PubMed ID: 12629277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of ischemic stroke onset time with presenting severity, acute progression, and long-term outcome: A cohort study.
    Ryu WS; Hong KS; Jeong SW; Park JE; Kim BJ; Kim JT; Lee KB; Park TH; Park SS; Park JM; Kang K; Cho YJ; Park HK; Lee BC; Yu KH; Oh MS; Lee SJ; Kim JG; Cha JK; Kim DH; Lee J; Han MK; Park MS; Choi KH; Lee J; Saver JL; Lo EH; Bae HJ; Kim DE
    PLoS Med; 2022 Feb; 19(2):e1003910. PubMed ID: 35120123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation and prestroke cognitive impairment in stroke.
    Horstmann S; Rizos T; Rauch G; Fuchs M; Arden C; Veltkamp R
    J Neurol; 2014 Mar; 261(3):546-53. PubMed ID: 24413641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation.
    Awadh M; MacDougall N; Santosh C; Teasdale E; Baird T; Muir KW
    Stroke; 2010 Sep; 41(9):1990-5. PubMed ID: 20705933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.